Bruno G. Frenguelli

Bruno G. Frenguelli

Auto-generated profile, based on publicly available information

Bruno G. Frenguelli

School of Life Sciences, University of Warwick, Coventry, CV4 7AL, UK

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1994 in Cell
Verified
Journal Article
Closed access
RBRoussoudan Bourtchuladze
Roussoudan Bourtchuladze
BFBruno Frenguelli
Bruno Frenguelli
JBJulie Blendy
Julie Blendy
DCDiana Cioffi
Diana Cioffi
GSGunther Schutz
Gunther Schutz
ASAlcino J. Silva
Alcino J. Silva

1 July 2005 in Cell Metabolism
Verified
Journal Article
Closed access
SHSimon A. Hawley
Simon A. Hawley
DPDavid A. Pan
David A. Pan
KMKirsty J. Mustard
Kirsty J. Mustard
LRLouise Ross
Louise Ross
JBJenny Bain
Jenny Bain
DHDavid Grahame Hardie
David Grahame Hardie

1 October 2000 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MWManus W. Ward
Manus W. Ward
Ana Cristina Cristina RegoAna Cristina Cristina Rego
Ana Cristina Cristina Rego
BFBruno G. Frenguelli
Bruno G. Frenguelli
DNDavid G. Nicholls
David G. Nicholls
The relationship between changes in mitochondrial membrane potential (Δψm) and the failure of cytoplasmic Ca2+ homeostasis, delayed Ca2+deregulation (DCD), is investigated for cultured rat cerebellar granule cells exposed to glutamate. To interpret the single-cell fluorescence response of cells loaded with tetramethylrhodamine methyl ester (TMRM+) or rhodamine-123, we devised and validated a mathematical simulation with well characterized effectors of Δψm and plasma membrane potential (ΔψP). Glutamate usually caused an immediate decrease in Δψm of <10 mV, attributable to Ca2+ accumulation rather than enhanced ATP demand, and these cells continued to generate ATP by oxidative phosphorylation until DCD. Cells for which the mitochondria showed a larger initial depolarization deregulated more rapidly. The mitochondria in a subpopulation of glutamate-exposed cells that failed to extrude Ca2+ that was released from the matrix after protonophore addition were bioenergetically competent. The onset of DCD during continuous glutamate exposure in the presence or absence of oligomycin was associated with a slowly developing mitochondrial depolarization, but cause and effect could not be established readily. In contrast, the slowly developing mitochondrial depolarization after transient NMDA receptor activation occurs before cytoplasmic free Ca2+([Ca2+]c) has risen to the set point at which mitochondria retain Ca2+. In the presence of oligomycin no increase in [Ca2+]c occurs during this depolarization. We conclude that transient Ca2+loading of mitochondria as a consequence of NMDA receptor activation initiates oxidative damage to both plasma membrane Ca2+ extrusion pathways and the inhibition of mitochondrial respiration. Depending on experimental conditions, one of these factors becomes rate-limiting and precipitates DCD.

1 September 2009 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
NDNicholas Dale
Nicholas Dale
BFBruno G. Frenguelli
Bruno G. Frenguelli
Eighty years ago Drury & Szent-Gyorgyi described the actions of adenosine, AMP (adenylic acid) and ATP (pyrophosphoric or diphosphoric ester of adenylic acid) on the mammalian cardiovascular system, skeletal muscle, intestinal and urinary systems. Since then considerable insight has been gleaned on the means by which these compounds act, not least of which in the distinction between the two broad classes of their respective receptors, with their many subtypes, and the ensuing diversity in cellular consequences their activation invokes. These myriad actions are of course predicated on the release of the purines into the extracellular milieu, but, surprisingly, there is still considerable ambiguity as to how this occurs in various physiological and pathophysiological conditions. In this review we summarise the release of ATP and adenosine during seizures and cerebral ischemia and discuss mechanisms by which the purines adenosine and ATP may be released from cells in the CNS under these conditions.

1 November 2006 in Learning & Memory
Verified
Journal Article
Closed access
PDF file
COColin M. O’cArroll
Colin M. O’cArroll
SMStephen J. Martin
Stephen J. Martin
JSJohan Sandin
Johan Sandin
BFBruno Frenguelli
Bruno Frenguelli
RMRichard G.M. Morris
Richard G.M. Morris
The persistence of new memory traces in the hippocampus, encoded following appropriate activation of glutamatergic receptors and the induction of synaptic plasticity, can be influenced by heterosynaptic activation of neuromodulatory brain systems. We therefore investigated the effects of a hippocampus-specific blockade of dopamine D1/D5 receptors on the persistence of spatial memory encoded in one trial using a delayed matching-to-place (DMP) task in a watermaze in which rats learn a new escape location each day. A within-subjects design was used such that both short (20 min) and long (6 h) retention intervals, and both drug (SCH23390, a D1/D5 receptor antagonist) and vehicle (aCSF) infusions were tested on different days in the same animals. Bilateral intrahippocampal infusion of SCH23390 (5 μg in 1 μL per side) prior to trial 1 (encoding) caused a differential impairment as a function of memory delay—with no effect during trial 2 (memory retrieval) after a 20-min interval, but a block of memory at 6 h. Further experiments revealed that infusion of SCH23390 immediately after trial 1 had no effect on retention 6 h later, and the poor memory seen at long retention intervals when the drug was present at encoding was not due to a state-dependent failure of retrieval. These results suggest that activation of D1/D5 receptors during memory encoding is necessary for the formation of a persistent memory trace in the hippocampus. The complementary effects of D1/D5 receptor blockade on the persistence of LTP and the duration of memory are consistent with the idea that changes in synaptic strength underlie memory.

4 January 2007 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
BFBruno G Frenguelli
Bruno G Frenguelli
GWGeoffrey Wigmore
Geoffrey Wigmore
ELEnrique Llaudet
Enrique Llaudet
NDNicholas Dale
Nicholas Dale
Adenosine is well known to be released during cerebral metabolic stress and is believed to be neuroprotective. ATP release under similar circumstances has been much less studied. We have now used biosensors to measure and compare in real time the release of ATP and adenosine duringin vitroischaemia in hippocampal slices. ATP release only occurred following the anoxic depolarisation, whereas adenosine release was apparent almost immediately after the onset of ischaemia. ATP release required extracellular Ca2+. By contrast adenosine release was enhanced by removal of extracellular Ca2+, whilst TTX had no effect on either ATP release or adenosine release. Blockade of ionotropic glutamate receptors substantially enhanced ATP release, but had only a modest effect on adenosine release. Carbenoxolone, an inhibitor of gap junction hemichannels, also greatly enhanced ischaemic ATP release, but had little effect on adenosine release. The ecto‐ATPase inhibitor ARL 67156, whilst modestly enhancing the ATP signal detected during ischaemia, had no effect on adenosine release. Adenosine release during ischaemia was reduced by pre‐treament with homosysteine thiolactone suggesting an intracellular origin. Adenosine transport inhibitors did not inhibit adenosine release, but instead they caused a twofold increase of release. Our data suggest that ATP and adenosine release during ischaemia are for the most part independent processes with distinct underlying mechanisms. These two purines will consequently confer temporally distinct influences on neuronal and glial function in the ischaemic brain.